Registration is now open for the Cambridge Pricing and Market Access Course for 2025

Developing a Successful Biopharmaceutical Pricing & Market Access Strategy

P&MA course, Thursdays, from April 24th until June 12th 2025 (1pm – 3 pm BST)

Registration is now open for the 2025 “Developing a Successful Biopharmaceutical Pricing & Market Access Strategy”, our executive education programme, which is a collaboration between Windrose Consulting Group and the University of Cambridge faculty of Bioscience Enterprise.

A Pricing & Marketing Access (P&MA) course, to develop the knowledge and skills required to deliver a successful Life Science commercial strategy and become an industry leader.

The course is a blend of lectures, case studies and practical exercises. We believe in an interactive approach, encouraging group discussion and exploring real-world situations. The aim is not just to provide theory, but help you understand how to apply it within your role or future career.

All course information can be found on our P&MA course page, which can be found by clicking below:

Learn more

About Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products. We develop strategies and recommendations focused on product and portfolio planning, pricing and market access, and value communication.

We deliver strategic insights and actionable recommendations that help our clients tackle complex challenges and drive better decision-making. As a private firm, we work with companies large and small, helping clients confidently navigate the commercial landscape and ultimately deliver innovations that enhance the health of individuals and communities.

Our primary clients are pharmaceutical and biotech companies. They range from global brands that operate in multiple markets to small companies with limited product portfolios. They come to us for strategic insights to guide commercial decision making, and to identify, capture, and communicate the value of their products.

Within our client companies, we work with cross-functional teams — mainly those in commercial and pricing and market access functions.

About Cambridge University MPhil in Bioscience Enterprise (MBE)

The Cambridge University MPhil in Bioscience Enterprise (MBE) programme is an intensive taught science and business course intended for those who have an interest in enterprise and the ambition to found technology companies or take up leadership, executive or consultancy roles in the life sciences sector.

The educational aims of the MBE are to:

enhance understanding of life sciences and related technological developments;
foster research and analytical skills and methodologies;
develop written and verbal communication skills;
provide knowledge of the ethical, legal and regulatory issues associated with bringing scientific advances to market; and
develop applied business skills, including those that enable students to:
identify potential business opportunities arising from research in life sciences and related areas;
exploit entrepreneurial opportunities; and
undertake senior executive roles within biotechnology companies and other commercial entities.

MBE students have the opportunity to learn from leading scientists, entrepreneurs and academics at the University of Cambridge, and from professionals within the Cambridge Cluster and wider industry.